MarkRapaportMD

PubMed

• Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with m...
  Stefania Lamon-Fava, Jisun So, David Mischoulon, Thomas R. Ziegler, Boadie W. Dunlop, Becky Kinkead, Pamela J. Schettler, Andrew A. Nierenberg, Jennifer C. Felger, Kri...> ;Prostaglandins Leukotrienes and Essential Fatty Acids. 2021 Jan 1
• Six versus twelve weeks of Swedish massage therapy for generalized anxiety disorder: Preliminary findings.
  Mark Hyman Rapaport, Pamela J. Schettler, Erika R. Larson, Boadie W. Dunlop, Jeffrey J. Rakofsky, Becky Kinkead> ;Complementary Therapies in Medicine. 2021 Jan 1
• Treatment of functional neurological disorder: current state, future directions, and a research agenda.
  Kathrin LaFaver, William Curt LaFrance, Michele Price, Phyllis Rosen, Mark Hyman Rapaport> ;Cns Spectrums. 2020 Dec 7
• Genome-Wide Association Studies of Schizophrenia and Bipolar Disorder in a Diverse Cohort of US Veterans
  Tim B. Bigdeli, Ayman H. Fanous, Yuli Li, Nallakkandi Rajeevan, Frederick G. Sayward, Giulio Genovese, Rishab Gupta, Krishnan Radhakrishnan, Anil K. Malhotra, Ning Sun...> ;Schizophrenia Bulletin. 2020 Nov 10
• Setting a Research Agenda for FND.
  Karen S. Rommelfanger, Mark Hyman Rapaport> ;Cns Spectrums. 2020 Oct 7
• 12 citations
  Contributions of common genetic variants to risk of schizophrenia among individuals of African and Latino ancestry
  Tim B. Bigdeli, Giulio Genovese, Penelope Georgakopoulos, Jacquelyn L. Meyers, Roseann E. Peterson, Conrad Iyegbe, Helena Medeiros, Jorge Valderrama, Eric D. Achtyes, ...> ;Molecular Psychiatry. 2020 Oct 1
• Application of Noninvasive Vagal Nerve Stimulation to Stress-Related Psychiatric Disorders.
  J D Bremner, Nil Z. Gurel, Matthew T. Wittbrodt, Md. Mobashir Hasan Shandhi, Mark Hyman Rapaport, Jonathon A. Nye, Bradley D. Pearce, Viola Vaccarino, Amit J. Shah, Je...> ;Journal of Personalized Medicine. 2020 Sep 9
• 3 citations
  Non-invasive vagal nerve stimulation decreases brain activity during trauma scripts.
  Matthew T. Wittbrodt, Nil Z. Gurel, Jonathon A. Nye, Stacy L. Ladd, Md. Mobashir Hasan Shandhi, Minxuan Huang, Amit J. Shah, Bradley D. Pearce, Zuhayr S. Alam, Mark Hy...> ;Brain Stimulation. 2020 Sep 1
• 1 citations
  Diet, Stress and Mental Health.
  J. Douglas Bremner, Kasra Moazzami, Matthew T. Wittbrodt, Jonathon A. Nye, Bruno B. Lima, Charles F. Gillespie, Mark Hyman Rapaport, Bradley D. Pearce, Amit J. Shah, V...> ;Nutrients. 2020 Aug 13
• Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits.
  David R. Goldsmith, Mark Hyman Rapaport> ;Frontiers in Psychiatry. 2020 Feb 20
• 42 citations
  Ultra-Rare Genetic Variation in the Epilepsies: A Whole-Exome Sequencing Study of 17,606 Individuals.
  Yen-Chen Anne Feng, Daniel P. Howrigan, Liam E. Abbott, Katherine Tashman, Felecia Cerrato, Tarjinder Singh, Henrike O. Heyne, Andrea Byrnes, Claire Churchhouse, Nicho...> ;American Journal of Human Genetics. 2019 Aug 1
• 9 citations
  Contribution of Rare Copy Number Variants to Bipolar Disorder Risk Is Limited to Schizoaffective Cases
  Alexander W. Charney, Eli A. Stahl, Elaine K. Green, Chia-Yen Chen, Jennifer L. Moran, Kimberly Chambert, Richard A. Belliveau, Liz Forty, Katherine Gordon-Smith, Phil...> ;Biological Psychiatry. 2019 Jul 15
• 2 citations
  Model structure for protocol adherence utilizing a manualized therapeutic massage intervention
  Erika R. Larson, Becky Kinkead, Sherry A. Edwards, Pamela J. Schettler, Boadie W. Dunlop, Jeffrey J. Rakofsky, Mark Hyman Rapaport> ;Journal of Complementary and Integrative Medicine. 2019 Jun 26
• 1 citations
  The prevalence and impact of psychiatric symptoms in an undiagnosed diseases clinical program
  Gabriella Waserstein, Clyde Partin, Debra Cohen, Pamela J. Schettler, Becky Kinkead, Mark Hyman Rapaport> ;PLOS ONE. 2019 Jun 6
• 8 citations
  Insomnia and suicidal ideation in nonaffective psychosis
  Brian J. Miller, Carmen B Parker, Mark Hyman Rapaport, Peter F. Buckley, William V. McCall> ;Sleep. 2019 Feb 1
• 14 citations
  Massage therapy decreases cancer-related fatigue: Results from a randomized early phase trial.
  Becky Kinkead, Pamela J. Schettler, Erika R. Larson, Dedric Carroll, Margaret Sharenko, James H. Nettles, Sherry A. Edwards, Andrew H. Miller, Mylin A. Torres, Boadie ...> ;Cancer. 2018 Feb 1
• 2 citations
  Massage Therapy for Psychiatric Disorders.
  Mark Hyman Rapaport, Pamela J. Schettler, Erika R. Larson, Dedric Carroll, Margaret Sharenko, James H. Nettles, Becky Kinkead> ;Focus (American Psychiatric Publishing). 2018 Jan 24
• 7 citations
  Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD).
  Maurizio Fava, Marlene P. Freeman, Martina Flynn, Bettina B. Hoeppner, Richard C. Shelton, Dan V. Iosifescu, James W. Murrough, David Mischoulon, Cristina Cusin, Mark ...> ;Brain Stimulation. 2018 Jan 1
• 2 citations
  Current Role of Herbal and Natural Preparations.
  David Mischoulon, Mark Hyman Rapaport> ;Handbook of experimental pharmacology. 2018 Jan 1
• 26 citations
  Impact of Ixekizumab Treatment on Depressive Symptoms and Systemic Inflammation in Patients with Moderate-to-Severe Psoriasis: An Integrated Analysis of Three Phase 3 ...
  Christopher E.M. Griffiths, Maurizio Fava, Andrew H. Miller, James A. Russell, Susan Ball, Wen Xu, Nayan Acharya, Mark Hyman Rapaport> ;Psychotherapy and Psychosomatics. 2017 Oct 1
• 7 citations
  Vagus Nerve Stimulation: Back to the Future
  J. Douglas Bremner, Mark Hyman Rapaport> ;American Journal of Psychiatry. 2017 Jul 1
• 12 citations
  Transdiagnostic Clinical Global Impression Scoring for Routine Clinical Settings.
  Boadie W. Dunlop, Jaclyn Gray, Mark Hyman Rapaport> ;Systems Research and Behavioral Science. 2017 Jun 27
• 8 citations
  Disentangling Stigma from Functional Neurological Disorders: Conference Report and Roadmap for the Future.
  Karen S. Rommelfanger, Stewart A. Factor, Suzette M. LaRoche, Phyllis Rosen, Raymond Young, Mark Hyman Rapaport> ;Frontiers in Neurology. 2017 Mar 29
• 1 citations
  Beyond the Psychiatric Horizon: Preparing Residents for the Twenty-First Century.
  Jeffrey J. Rakofsky, Robert O. Cotes, William M. McDonald, Ann C. Schwartz, Mark Hyman Rapaport> ;Academic Psychiatry. 2017 Feb 1
• Introducing a New Section: The Applied Armamentarium.
  Mark Hyman Rapaport> ;Focus (American Psychiatric Publishing). 2017 Jan 17
• Join now to see all

Books/Book Chapters

• Psychiatry, 
  Chapter: "Anxiolytic Drugs" 
  Saah TC, Garlow SJ, Rapaport MH, Edwards DM, Hale KL, Maddux, REEditors: A Tasman, J Kay, J Lieberman, M First and M Maj.John Wiley & Sons, Ltd.Edition 4th,2014
• Child Adolesc Psychiatric Clin N Am 
  Chapter: "Building an Evidence Base in Complementary and Integrative Healthcare for Child & Adolescent Psychiatry" 
  Page 509 - 529Edwards E, Mischoulon D, Rapaport MH, Stussman B, Weber WElsevier, Inc.2013
• FOCUS, Maintenance of Certification (MOC) Workbook 
  Chapter: "Major Depressive Disorder" 
  Hales DJ, Rapaport MH, Moeller KAPPI Press2013
• FOCUS, Psychiatry Review 
  Chapter: "400 All New Multiple Choice Questions." 
  Hales DJ, Rapaport MHAPPI Press2011
• The American College of Neuropsycho Pharmacology Textbook of Psychopharmacology 
  Chapter: "Treatment of Depression." 
  Page 1081 - 1111Bresee CJ, Gotto J, Rapaport MHEditors: Schatzberg AF, Nemeroff CB.APPIEdition Four,2009
• Mood and Anxiety Disorders 
  Chapter: "Quality of life impairment in anxiety disorders." 
  Page 275 - 291Koury MA, Rapaport MHEditors: M.S.Ritsner and A.G. Awad.Springer2007
• FOCUS, Psychiatry Review 
  Chapter: "400 Self-Assessment Questions." 
  Hales DJ, Rapaport MHAPPI Press2007
• Handbook of Chronic Depression: Diagnoses and Therapeutic Management 
  Chapter: "Psychopharmacology and psychotherapy of subsyndromal depressions." 
  Page 183 - 206Maddux RE, Rapaport MHEditors: Alpert, Fava.Marcel Dekker2004
• World Psychiatric Association: Evidence and Experience in Psychiatry 
  Chapter: "Burden of phobias: Focus on health-related quality of life." 
  Rapaport MH, Delrahim KK, Maddux REJohn Wiley & Sons Ltd., London2004
• Psychiatry 
  Chapter: "Anxiolytic Drugs." 
  Page 2033 - 2049Maddux RE, Rapaport MHEditors: Tasman A, Kay J, Lieberman J.Wiley & SonsEdition Seco,2003
• Psychoneuroimmunology 
  Chapter: "Immunological states associated with schizophrenia." 
  Page 373 - 382Rapaport MH, Muller NEditors: Ader, Felten, Cohen.Edition Thir,2001
• Psychiatric Clinics of North America 
  Chapter: "Anxiety Disorders." 
  Page 181 - 208Barrett C, Rapaport MH2001
• Psychiatry, Psychoimmunology, and Viruse 
  Chapter: "A preliminary analysis investigating immune activation in schizophrenia." 
  Page 101 - 114Rapaport MH, Caliguiri M, Lohr JB, Dolnak D, Chavez S, Kulesh C, Hahn TEditors: Muller N.1999
• Basic and Clinical Science of Mental and Addictive Disorders 
  Chapter: "The role of subsyndromal depressive symptoms in unipolar major depression." 
  Page 6 - 10Judd LL, Paulus M, Akiskal HS, Rapaport MH, Kunovac JLEditors: Judd LL, Saletu B, and Filip V.Karger Press, Basel, Switzerland1997
• Excerpta Medica IX World Congress of Psychiatry 
  Chapter: "New subtypes of depression: implications for research." 
  Rapaport MH, Judd LLElsevier Press1994
• Exerpta Medica VIII World Congress of Psychiatry 
  Chapter: "Immunological findings in schizophrenia." 
  Rapaport MHElsevier1991
• Psychoimmunology Updates 
  Chapter: "Neuroimmunological factor in schizophrenia." 
  Page 31 - 54Rapaport MH, McAllister CGEditors: Gorman and Kertzner.Amer Psych Press1991
• Schizophrenia 
  Chapter: "The role of autoimmunity in schizophrenia." 
  McAllister CG, Rapaport MH, Paul SMEditors: Schultz and Tamminga.Raven Press1991
• Augmentation Strategies for Treatment Refractory Schizophrenic Patients 
  Chapter: Benzodiazepine augmentation of neuroleptics 
  Wolkowitz OM, Rapaport MH, Pickar DEditors: Schultz and Angrist.Amer Psych Press, Washington, DC1990
• Amer Psych Assoc Annual Update 
  Chapter: "The neurobiology of sleep: basic concepts and clinical implications." 
  Shiromani P, Rapaport MH, Gillin JCEditors: Hales and France.Washington, DC1987
• The American College Neuropsychopharmacology Textbook of Psychopharmacology 
  Chapter: "Treatment of Depression" 
  Shaywitz J, Rapaport MHEditors: Schatzberg AF, Nemeroff CB.APPIEdition Fift,
• Join now to see all

Abstracts/Posters

• "Inflammation, Depression and N-3 Fatty Acids: A Case of Personalized Medicine"
  Rapaport MH, Schettler PJ, Pace TW, Kinkead B, Nierenberg AA, Mischoulon D, ACNP 52nd Annual Meeting, Hollywood, FL, 1/1/2013
• "Innovations in Lifelong Learning for Psychiatrists: The Focus System"
  Rapaport MH, Hales D, Moeller K, 52nd Annual NCDEU Meeting, Phoenix, AZ, 1/1/2012
• "The Efficacy of Memantine for Cognitive Deficits in Euthymic Subjects with Bipolar Disorder"
  Isofescu D, Gilmer W, Fan A, Gonenc A, Moore C, Randolph C, Rapaport MH, Deckersbach T, and Nierenberg A, 52nd Annual NCDEU Meeting, Phoenix, AZ, 1/1/2012
• "The Efficacy of the Glutamate NMDA Receptor Antagonist Memantine for Cognitive Deficits in Euthymic Subjects with Bipolar Disorder"
  Iosifescu D, Gilmer W, Fan A, Gonenc A, Moore C, Randolph C, Rapaport MH, Deckersbach T, and Nirenberg A, ACNP 51st Annual Meeting, Hollywood, FL, 1/1/2012
• "Use of Audio-Digital Recordings for External Monitoring to Improve Subject Selection in a Schizophrenia Trial."
  Rapaport MH, Little J, Ereshefsky L, Demartinis N, Targum S, 51st Annual NCDEU Meeting, Boca Raton, FL, 1/1/2011
• "Treating Major Depressive Disorder by Creating Positive Expectations for the Future: A Study for the Efficacy of Future Directed Therapy (FDT)"
  Rapaport, MH, 51st Annual NCDEU Meeting, Boca Raton, FL, 1/1/2011
• "The Biology of Massage: Implications for Psychiatry."
  Rapaport MH, Bresee C, Schettler P, ACNP 49th Annual Meeting, Miami Beach, FL, 1/1/2010
• "Compound Identified by Neurogenesis Platform Shows Promising Efficacy in Treatment of Patients with Major Depressive Disorder with Concomitant Generalized Anxiety Dis...
  Wedel PC, Barlow C, Bleicher LS, Carter TA, Dearie AR, Defratis-robinson J, Drayer JI, Lee DM, Lorrain KI, Pires JC, Rapaport MH, Seehus CR, Schettler PJ, Stoveken BS,..., Society of Neuroscience, 40th Annual Meeting, San Diego, CA, 1/1/2010
• "Use of a Relapse Monitoring Board for Independent Assessment of the Primary End Point in an International Clinical Trial of Bipolar Disorder."
  Turner N, Macfadden W, Anand R, Khanna S, Rapaport MH, Haskins T, Turkoz I, Alphs L, ISCTM Annual Meeting, 1/1/2009
• "Quality of Life in Major Depressive Disorder in a Naturalistic Treatment Setting."
  IsHak WW, Rapaport MH, 49th Annual NCDEU Meeting, 1/1/2009
• "Assessment of the Maximum Tolerated Dose (MTD) of Lurasidone in Patients with Schizophrenia."
  Ereshefsky L, Jhee S, Phillips D, Peterson M, Ogasa M, Gertsik, Loebel A, Rapaport MH, ACNP 48th Annual Meeting, Hollywood, FL, 1/1/2009
• "Quality of Life of Patients with Major Depression in a Natural Clinical Setting"
  Rapaport MH, IsHak WW, FOCUS Live Session, APA Annual Meeting, Washington, DC, 1/1/2008
• "The Role of Oxytocin, Vasopressin and Cortisol in the Beneficial Effects of Massage."
  Rapaport MH, Hale KL, Koury MA, Shubov A, Bresee KJ, Society of Biological Psychiatry, 1/1/2008
• "The Beneficial Effects of Massage Therapy on Psychiatric and Biological Measures."
  Rapaport MH, Koury MA, Hale KL, Bresee KJ, Society of Biological Psychiatry 62nd Annual Scientific Convention and Meeting, 1/1/2007
• "The Effects of Acute and Continuous Massage Therapy on the HPA Axis and Immune Function."
  Rapaport MH, Bresee KJ, American College of Neuropsychopharmacology, 1/1/2007
• "Cytokine Alterations in Medication-Stabilized Patients with Schizophrenia."
  Rapaport MH, Bresee K, Society for Biological Psychiatry 61st Annual Meeting, 1/1/2006
• "A New Approach for Assessing Patients with Generalized Anxiety Disorder or Major Depression and Residual Symptoms."
  Anand R, Gharabawi G, Greist J, Rapaport MH, Sheehan D, American Psychiatric Association 159th Annual Meeting, 1/1/2006
• "Clinical Psychopharmacology and Neurosciences: Keeping-up by Tailoring the Curriculum to the Constituency."
  Glick ID, Rapaport MH, Ketter TA, Zisook S, NCDEU, 1/1/2006
• "Efficacy and Safety of Bifeprunox versus Placebo in the Treatment of Patients with Acute Exacerbations of Schizophrenia."
  Rapaport MH, Barbato LM, Heisterberg J, Yeung PP, Shapiro NA, American College of Neuropsychopharmacology 45th Annual Meeting, 1/1/2006
• "COX-2 Inhibitor Augmentation Therapy for Schizophrenia."
  Rapaport MH, et al, Biological Psychiatry 60th Annual Convention and Scientific Program, 1/1/2005
• "Risperidone Augmentation of Treatment-Resistant Depression: Brain Metabolite Alterations Associated with Treatment Response"
  Gertsik L, Moser F, Rapaport MH, et al, Biological Psychiatry 60th Annual Convention and Scientific Program, 1/1/2005
• "Fluoxetine Not Found to Increase Suicidality Over Placebo During Treatment of Adults with Minor Depressive Disorder."
  Thase ME, Rush JA, Rapaport MH, et al, Biological Psychiatry 60th Annual Convention and Scientific Program, 1/1/2005
• "Clinical Characteristics of Patients With Minor Depression."
  Howland RH, Nierenberg A, Rapaport MH, APA, 1/1/2005
• "Treatment Augmentation with Risperidone for Patients with Resistant Depression."
  Rapaport MH, Canuso CM, Rouillon F, Leblanc J, Young AH, Loescher A, Bossie CA, Turkoz I, Gharabawi GM, and the ARISe-RD Study Group, APA, 1/1/2004
• "Improvement in Quality of Life with Risperidone Augmentation in Resistant Depression."
  Walling D, Rapaport MH, Rupnow MFT, Canuso CM, Gharabawi GM, APA, 1/1/2004
• Join now to see all

Lectures

• Grand Rounds: "Inflammation, Depression, Omega-3 Fatty Acids: A Proof of Concept" 
  UCLA Semel Institute, Los Angeles, CA - 1/1/2014
• Panel Presentation: "How does Massage Work? Potential Mechanisms" 
  Massage Therapy Foundation, Boston, MA - 1/1/2013
• "Maintenance of Certification Workshop" 
  Atlanta, GA - 1/1/2013
• FOCUS "Major Depressive Disorder Maintenance of Certification (MOC) Workbook", Small Interactive Sessions 
  San Francisco, CA - 1/1/2013
• "Immunotherapeutic approaches for the treatment of depression" 
  Kyoto, Japan - 1/1/2013
• Workshop 69: "ABPN and APA Perspectives on "Maintenance of Certification" 
  San Francisco, CA - 1/1/2013
• NCDEU NIA Program Panel Discussion, "Extramural Perspective" 
  Hollywood, FL - 1/1/2013
• NCDEU NIA Program, "Getting a Job and Keeping It? 
  Hollywood, FL - 1/1/2013
• "Residual Symptoms in Depression: Management and Prognosis" 
  Shanghai Mental Health Center, Shanghai, PR China - 1/1/2012
• Symposium "Psychoneuroimmunology in the Service of Personalized Medicine in Psychiatry" 
  Prague, Czech Republic - 1/1/2012
• Mental Health Lecture Series, "A Review of CAM Treatments for Mood and Anxiety Disorders, the Good, the Bad and the Ugly" 
  School of Public Health, Emory University, Atlanta, GA - 1/1/2012
• "Mood Disorders" 
  The Carter Center, Atlanta, GA - 1/1/2012
• Special Session: "Innovations in Life Long Learning for Psychiatrists: The Focus System" 
  Phoenix, AZ - 1/1/2012
• "CAM: Implications for Mood & Anxiety Disorders" 
  Philadelphia, PA - 1/1/2012
• "Bipolar Spectrum Disorders: Underdiagnosed? Over-diagnosed? Strategies for Treatment" 
  1/1/2012
• "Off the Couch: Why Atlanta Can Transform Psychiatry in the 21st Century" 
  Skyland Trail, Atlanta, GA - 1/1/2011
• "Complementary and Alternative Medicine" 
  Toronto, Canada - 1/1/2011
• "Grant Writing Workshop for Complementary and Integrative Medicine" 
  Toronto, Canada - 1/1/2011
• "Major Depressive disorder: Where are We Going?" 
  Las Vegas, NV - 1/1/2011
• "Diagnosis and Treatment of Bipolar Disorder" 
  Tucson, AZ - 1/1/2011
• Grand Rounds: "Complementary and Alternative Therapies for Mood and Anxiety Disorders: The Good, the Bad, and the Ugly" 
  Georgia Health University, Augusta, GA - 1/1/2011
• "Psychopharmacology for Depression and Mood Disorders: Tips for Success" 
  Atlanta, GA - 1/1/2011
• Case Presentation: "What Next? A case Presentation of Treatment Resistant Depression" 
  Atlanta, GA - 1/1/2011
• Round Table Discussion: "Immunology and Psychiatry" 
  Munich, Germany - 1/1/2010
• "Immune Sequelae in Schizophrenia: the Quest for Testable Hypotheses" 
  Munich, Germany - 1/1/2010
• Join now to see all

Other

• "A placebo-controlled study of topiramate in acute mania (bipolar I disorder): Trials and tribulations of conducting an acute mania study." 
  Van Kammen DP, Chengappa KNR, Shiwach R, Lesem M, Wang D, Topamax Psychiatry Phase II Study Group
  1/1/2003
• "Case history: major depressive disorder in a middle-aged female" 
  Zisook S, Rapaport MH
  Medical Age Publishing, Norwalk, CT - 1/1/1997